Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :26439969
Publication Date : //

Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.


Data from in vitro and animal studies support a neuroprotective role of glatiramer acetate (GA) in multiple sclerosis (MS). We investigated prospectively whether treatment with GA leads to clinical and paraclinical changes associated with neuroprotection in patients with relapsing-remitting (RR) MS. Primary aim of this clinical study was to determine serum BDNF levels in RR-MS patients who were started on GA as compared to patients who remained therapy-naive throughout 24 months. Secondary outcomes included relapses and EDSS, cognition, quality of life, fatigue and depression, BDNF expression levels on peripheral immune cells (FACS, RT-PCR), serum anti-myelin basic peptide (MBP) antibody status, evoked potential and cerebral MRI studies. While GA treatment did not alter serum levels or expression levels on peripheral immune cells of BDNF over time it resulted in a transient increase of serum IgG antibody response to MBP, mainly due to subtype IgG1 (p<0.05), after 3 months. However, no significant differences were found between GA treated and therapy-naive patients with regard to serum BDNF and intracellular BDNF expression levels, nerve conduction (including median and tibial nerve somatosensory, pattern-shift visual and upper and lower limb motor evoked potentials) or MRI (including volume of hyperintense lesions, volume of hypointense lesions after CE, mean diffusivity and fractional anisotropy) outcome parameters. In conclusion, our findings do not support a major impact of GA treatment on paraclinical markers of neuroprotection in human RR-MS.

Authors : Ehling Rainer , Di Pauli Franziska , Lackner Peter , Rainer Carolyn , Kraus Viktoria , Hegen Harald , Lutterotti Andreas , Kuenz Bettina , De Zordo Tobias , Schocke Michael , Glatzl Susanne , Löscher Wolfgang N , Deisenhammer Florian , Reindl Markus , Berger Thomas ,

Related products :

Catalog number Product name Quantity
orb61232 Carfilzomib Carfilzomib was discovered and advanced to multiple Phase 1 and 2 clinical trials, including a pivotal Phase 2 clinical trial designed to seek accelerated approval, by Proteolix, Inc. For 5 mg
147245-92-9 Glatiramer Acetate Glatiramer Acetate 1g
PP-1120 Copaxone acetate (Glatiramer acetate) Species Reactivity: Bulk Product tipe: Chemicals/Drugs
PP-1120 Copaxone acetate (Glatiramer acetate) Bulk
G406800 Glatiramer Acetate C25H45N5O13 CAS: 147245-92-9 10 mg
MS3 MS Gene multiple sclerosis
IMPCT_MOUSE ELISA Kit FOR Protein IMPACT; organism: Mouse; gene name: Impact 96T
IMPCT_HUMAN ELISA Kit FOR Protein IMPACT; organism: Human; gene name: IMPACT 96T
CSB-EL011696RA Rat Impact homolog (mouse) (IMPACT) ELISA kit, Species Rat, Sample Type serum, plasma 96T
CSB-EL011696MO Mouse Protein IMPACT(IMPACT) ELISA kit SpeciesMouse 96T
IMPCT_RAT ELISA Kit FOR Protein IMPACT; organism: Rat; gene name: Impact 96T
CSB-EL011696HU Human Protein IMPACT(IMPACT) ELISA kit SpeciesHuman 96T
CSB-EL011696RB Rabbit Protein IMPACT(IMPACT) ELISA kit SpeciesRabbit 96T
CSB-EL011696BO Bovine Protein IMPACT(IMPACT) ELISA kit SpeciesBovine 96T
orb61275 OSI-027 OSI-027 is a potent, selective and orally bioavailable mTOR inhibitor currently in clinical trial. For research use only. 5 mg
G3397 Protein IMPACT (IMPACT), Mouse, ELISA Kit 96T
G3398 Protein IMPACT (IMPACT), Rabbit, ELISA Kit 96T
G3396 Protein IMPACT (IMPACT), Human, ELISA Kit 96T
IMPDH1 IMPACT Gene Impact homolog (mouse)
CSB-EL011696BO Bovine Protein IMPACT(IMPACT) ELISA kit 96T
CSB-EL011696RA Rat Protein IMPACT(IMPACT) ELISA kit SpeciesRat 96T
G3395 Protein IMPACT (IMPACT), Bovine, ELISA Kit 96T
CSB-EL011696HU Human Protein IMPACT(IMPACT) ELISA kit 96T
CSB-EL011696MO Mouse Protein IMPACT(IMPACT) ELISA kit 96T
MS1H1_B12S Multiple Sclerosis ,MS1H1,12 SignArrays


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur